View in EDS HTML Full Text PDF Full Text

Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study.

Saved in:
Bibliographic Details
Title: Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study.
Authors: Deng, Rong1 (AUTHOR) deng.rong@gene.com, Gibiansky, Leonid2 (AUTHOR), Lu, Tong1 (AUTHOR), Flowers, Christopher R.3 (AUTHOR), Sehn, Laurie H.4 (AUTHOR), Liu, Qi1 (AUTHOR), Agarwal, Priya1 (AUTHOR), Liao, Michael Z.1 (AUTHOR), Dere, Randall1 (AUTHOR), Lee, Calvin1 (AUTHOR), Man, Gabriel1 (AUTHOR), Hirata, Jamie1 (AUTHOR), Li, Chunze1 (AUTHOR), Miles, Dale1 (AUTHOR)
Source: CPT: Pharmacometrics & Systems Pharmacology. Jun2024, Vol. 13 Issue 6, p1055-1066. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21638306
DOI:10.1002/psp4.13141